Collection of Information-Rich Type 1 Diabetes Data

The aim of this clinical study was to obtain type 1 diabetes data to identify models for glucose prediction and control and to construct a physiological pharmaco-kinetic/pharmaco-dynamic computer model of a type 1 diabetic person.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 1 Diabetes Autoimmune Diseases Diabetes Mellitus Diabetes Mellitus, Type 1 Endocrine System Diseases Glucose Metabolism Disorders Immune System Diseases Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hvidovre University Hospital

Hvidovre, 2650, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

diabetes duration > 5 years
HbA1c < or = 7.2%
CSII treated for > 3 months
Capable of being moderately, physically active for 20 minutes

Exclusion criteria

symptoms of diabetic late complications except simplex retinopathy
pregnancy or nursing

Treatment and study plan

insulin aspart

Drug

Insulin bolus with and without carbohydrate intake.

Exercise

Other

Exercise on tread mill

Carbohydrate

Dietary Supplement

Carbohydrate intake

Sponsors and collaborators

Lead sponsor

Hvidovre University Hospital

Other

Collaborators

Novo Nordisk A/S
Technical University of Denmark
The Danish Council for Strategic Research

Registry information

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Oct 19, 2010
Registry last updated: Oct 19, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed